01
Biomarker science
Multimodal signals spanning eye movement, speech, and behavior—validated against clinical ground truth.
Medical-grade tools for dementia subtyping and objective cognitive task performance—built with partners across Japan, India, and the US.
We turn subtle cognitive and behavioral markers into dependable, medical-grade insights—so clinicians can detect earlier and intervene with confidence.
01
Multimodal signals spanning eye movement, speech, and behavior—validated against clinical ground truth.
02
Designed for real care and research settings: clear sessions, dependable measurement, and workflows that fit existing pathways.
03
Built to HIPAA standards, advancing alongside FDA, PMDA, and CDSCO pathways with hospital and research collaborators worldwide.
Peer-reviewed science, recognized work, and protected IP—backing every product decision.
Product suite
Mayamind® and Nimixa™ lead today—with more precision tools on the roadmap as we expand across neuropsychiatric care.
We operate at the intersection—collaborating with hospitals, research institutes, and regulatory experts to move innovation from lab benches to bedside.
Be part of the innovation—clinicians, researchers, and partners welcome.